600594 Stock Overview
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Guizhou Yibai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.98 |
| 52 Week High | CN¥6.35 |
| 52 Week Low | CN¥3.77 |
| Beta | 0.42 |
| 1 Month Change | -15.14% |
| 3 Month Change | -22.87% |
| 1 Year Change | -29.81% |
| 3 Year Change | -33.89% |
| 5 Year Change | -38.29% |
| Change since IPO | 61.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600594 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.9% | 3.0% | 1.6% |
| 1Y | -29.8% | -12.9% | -15.1% |
Return vs Industry: 600594 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 600594 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 600594 volatility | |
|---|---|
| 600594 Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 600594's share price has been volatile over the past 3 months.
Volatility Over Time: 600594's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 5,555 | Ya Qi Dou | www.gzcci.com |
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
Guizhou Yibai Pharmaceutical Co., Ltd. Fundamentals Summary
| 600594 fundamental statistics | |
|---|---|
| Market cap | CN¥3.17b |
| Earnings (TTM) | -CN¥9.06m |
| Revenue (TTM) | CN¥2.71b |
1.2x
P/S Ratio-348.1x
P/E RatioIs 600594 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600594 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.71b |
| Cost of Revenue | CN¥942.75m |
| Gross Profit | CN¥1.77b |
| Other Expenses | CN¥1.78b |
| Earnings | -CN¥9.06m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 65.20% |
| Net Profit Margin | -0.33% |
| Debt/Equity Ratio | 22.2% |
How did 600594 perform over the long term?
See historical performance and comparison